Healthtech startup In-Med Prognostics has received a Biotechnology Ignition Grant of Rs 50 Lakhs for a duration of 18 months from the Biotechnology Industry Research Assistance Council (BIRAC), Government of India.
The pune-based startup is working at developing a software platform for early detection and assessment of neurological disorders like dementia, Alzheimer’s and Parkinson’s. It will use the fund to develop a cloud-based software platform that will label, visualize, and quantify the volumes of brain structures using 3D MRI images.
“Our proprietary software ‘Neuroshield’, addresses the need of the hour in neurology: accurate volumetric analysis of the brain and its structures. We will be leveraging deep learning algorithm and machine learning to provide time saving accurate Neuro analysis which will aid in assessment and early detection of neurological disorders such as Dementia, Alzheimer’s and Parkinson’s at affordable prices,” Rajesh Purushottam, Co-founder In-Med Prognostics was quoted as saying.
“The proposed solution is to provide a self-explicative volumetric report within an analysis time of 20 minutes,” he further stated.
Founded by Purushottam, Latha Poonamallee and Al Curran, In-Med Prognostics, the startup aims at bringing affordable, accessible, evidence-based brain health diagnostic and prognostic tools to India and other emerging markets.
An initiative of Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology, Government of India, Biotechnology Ignition Grant (BIG) supports innovative ideas. It is India’s largest early stage biotech startup funding programme.